From Data to Treatment: Medidata's Fareed Melhem Discusses AI's Impact on Clinical Trials
As the potential of artificial intelligence (AI) continues to unfold, how is it revolutionizing the intricate landscape of clinical trials? …
Interviews
Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences
In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on …
U.S. Frontiers in Biotech: Interview with Abigail Kukura about Strategy, Science, and the Road Ahead
Biotechnology is more than just an emerging scientific frontier, it also impacts global economy, competition, and societal transformation. To learn …
How AbbVie Addresses Individuals Living with Migraine in Europe: Interview with Michael Seminerio
In August, AbbVie has secured European Commission (EC) approval for AQUIPTA® (atogepant) as a preventive treatment for adults experiencing four …
On Biotech Engineering and AI: a Conversation with TeselaGen's CEO, Eduardo Abeliuk
Navigating the dynamic intersection of biology and data science, Eduardo Abeliuk, the CEO of TeselaGen Biotechnology, invites us on a …
Dr. James Field on Breaking the 'Cognition Barrier' in Antibody Discovery with AI and Robotics
We're fortunate to speak with Dr. James Field, founder and CEO of LabGenius, a leading machine learning (ML)-driven protein engineering …
Reimagining Genomics Data Analysis: Interview with Paolo Di Tommaso from Seqera Labs
With BioNTech’s recent $200 million merger with OncoC4’s cancer drug, the demand for personalised medicines to treat diseases such as cancer …
Breaking Through the Investment Gap: Mark Andrews Discusses British Patient Capital's Life Sciences Fund
In this interview, we speak with Mark Andrews, Investment Director, Life Sciences, Funds at British Patient Capital, the largest domestic …
Biopharma Financial Climate and Market Dynamics in 2023: Interview with David Dowling, Ropes & Gray
Recently, David Dowling, a senior lawyer at Ropes & Gray, has outlined his predictions for M&A in the European biotech …
Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung
Before the age of modern drug discovery, the pharmaceutical industry had been plagued with uncertainty and processing challenges, including the …
A Look at Longevity Industry: Interview with Dr. Eric Leire, CEO of Genflow Biosciences
The aging research industry has exploded in recent years. Once a fringe area of science, aging research has now gained …
Innovation and Sustainability Trends for 2023: Interview with Jesper Jonsson, Director of Medical Devices at Owen Mumford
The medical device industry is driven by constant innovation, and the annual Medica conference offers the chance to discover the …